Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lea Löffler1, Ismail Gögenur1,2,3, Susanna Brix4

  • 1Center for Surgical Science, Kirurgisk Afdeling, Sjællands Universitetshospital, Køge.

Ugeskrift for Laeger
|August 25, 2023
PubMed
Summary

Targeted delivery of Interferon type I (IFN-I) proteins to the tumor microenvironment (TME) shows promise for treating solid cancers. Further research into IFN-I mechanisms is crucial for developing improved cancer therapies.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining genome-wide polygenic scores with registry data for colorectal cancer risk-based screening.

British journal of cancer·2026
Same author

Diagnostic performance of real-time characterization in artificial intelligence-assisted colonoscopy.

Endoscopy international open·2026
Same author

Long-term survival in generalized peritonitis: the impact of early critical periods in major emergency abdominal surgery.

BMC surgery·2026
Same author

The effect of dexamethasone on inflammatory markers of surgical stress: a randomized trial in robotic hysterectomy.

BMC surgery·2026
Same author

Response to Koulaouzidis et al. and Sharma et al.

Journal of the National Cancer Institute·2026
Same author

Whole Blood Transcriptomic Response to Perioperative Dexamethasone in Total Knee Arthroplasty: A Targeted Panel Analysis.

Acta anaesthesiologica Scandinavica·2026

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Tumor microenvironment (TME) interactions present complex challenges in cancer treatment.
  • Immunotherapy has advanced cancer care, but patient response varies.
  • Modulating the TME is a growing area of clinical research.

Conclusions:

  • Targeted intratumoural delivery of IFN-I offers a promising strategy for solid cancer treatment.
  • Understanding IFN-I mechanisms within the TME is essential for future therapeutic development.
  • IFN-I modulation holds significant potential for advancing clinical oncology.